Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience GlobeNewswire - Fri Dec 19, 7:45AM CST

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns GlobeNewswire - Wed Dec 10, 7:30PM CST

TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids,...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Completes First Shipment to France GlobeNewswire - Thu Dec 4, 7:40AM CST

TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law GlobeNewswire - Fri Nov 14, 9:00AM CST

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ MediPharm ” or the “ Company ”), a pharmaceutical company specialized in precision-based...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains GlobeNewswire - Thu Nov 13, 7:00AM CST

Q3 2025 Revenue of $11.4 Million, an Increase of 17% over Q3 2024 83% Growth in Year-Over-Year Revenue for International Medical Cannabis International Medical sales now 56% of Total Revenue Increased...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results GlobeNewswire - Mon Nov 10, 5:00PM CST

TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders PR Newswire - Fri Nov 7, 3:20PM CST

TORONTO , May 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (" MediPharm " or the " Company "), a pharmaceutical company specialized in precision-based cannabinoids, has filed...

LABS.TO : 0.0750 (+7.14%)
Stocks in play: MediPharm Labs Corp. Baystreet - Thu Aug 14, 10:32AM CDT

Today announced its financial results for the three months ended June 30, 2025. Q2 Revenue was $11.8 ...

LABS.TO : 0.0750 (+7.14%)
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis GlobeNewswire - Thu Aug 14, 6:30AM CDT

Q2 Revenue of $11.8 Million, an Increase of 14% over Q2 2024 50% Growth in Revenue for International Medical Cannabis International Medical sales now 57% of Total Revenue Cash Balance of $10.4 Million...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)
MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States PR Newswire - Wed Aug 13, 6:30AM CDT

TORONTO , Aug. 13, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based...

MEDIF : 0.0531 (+1.72%)
LABS.TO : 0.0750 (+7.14%)

Barchart Exclusives

Amazon Could Invest $10 Billion in OpenAI. Should You Invest in AMZN Stock First? Barchart - Sun Dec 21, 1:30PM CST
Amazon is reportedly weighing a bold multi-billion $ bet on OpenAI, which can deepen its dominance in the AI race. Is AMZN a buy now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot